Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2012. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding the GlaxoSmithKline Performance Share Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific equity transaction rather than general financial performance.
Material Changes
The filing reports an increase in notional interests in Ordinary Shares for a connected person following the notional re-investment of a dividend paid on April 12, 2012. The transaction price was 1420 pence per Ordinary Share.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It notes that notional dividends accrued will be paid out in proportion to the percentage of the participant's Performance Share Plan holdings that vest following the end of the relevant three-year measurement period.
Important Facts for Investors
- Transaction Type: Notional re-investment of dividends under the Performance Share Plan.
- Individuals Involved: Director Mr. P C Thomson and Connected Person Mrs. K Thomson.
- Share Quantity: 75.461 Ordinary Shares.
- Transaction Price: 1420 pence per Ordinary Share.
- Dividend Date: April 12, 2012.
- Regulatory Basis: Notification made in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).